Genta Announces One Time Non-Recurring Gain For Year-Ended 2000

BERKELEY HEIGHTS, NJ, April 2, 2001 - Genta Incorporated (Nasdaq: GNTA) announced today that it had recorded a one-time gain of $4.9 million for fiscal year 2000 as a result of the exercise and sale of warrants related to a 1993 licensing arrangement with CV Therapeutics. This gain will reduce the Companys previously announced net loss of $20.8 million, or $(0.54) per common share, to a net loss of $15.9 million or $(0.41) per common share.